Oxford Biomedica plc (LSE:OXB) entered into a sale and purchase agreement to acquire additional 3.2% stake in ABL EUROPE S.A.S. from TSGH on December 4, 2023.

Oxford Biomedica plc (LSE:OXB) completed the acquisition of additional 3.2% stake in ABL EUROPE S.A.S. from TSGH for ?6.1 million on January 29, 2024. As of February 22, 2024, Matthew EdwardsOsborne of Clarke LLP and Catherine Olive Osborne, Jérôme Scapoli, Thomas Devred, Xavier Pican, François-Régis Fabre-Falret, Dorothée Chambon, and Lucie Mongin-Archambeaud of Clarke SELAS acted as legal advisor to Oxford Biomedica plc.